Human anti-Core Antigen of Hepatitis B Virus IgM Antibody / HBc IgM ELISA Kit INQUIRY

Cat.No: EHB-138
Prod. No. EHB-138
Product Name Human anti-Core Antigen of Hepatitis B Virus IgM Antibody / HBc IgM ELISA Kit
Intended use This anti-HBc IgM kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative determination of IgM class antibodies to hepatitis B virus core antigen in human serum or plasma. It is intended for use in clinical laboratories for diagnosis and management of patients related to infection with hepatitis B virus.
Principle Of The Test This kit is a two-step incubation, solid phase antibody capture
ELISA assay, in which polystyrene microwell strips are pre-coated with antibodies directed to human immunoglobulin M proteins (anti-μ chain). The patient’s serum/plasma sample is added and during the first incubation step, any IgM-class antibodies will be captured inside the wells. After washing out all other components of the sample and in particular IgG-class antibodies, the specific anti-HBc IgM captured on the solid phase is detected by the addition of purified HBcAg, labeled with anti-HBc monoclonal antibody conjugated to horseradish peroxidase (HRP-Conjugate antibody). During the second incubation, the HRP-conjugated antigens will specifically react only with anti-HBc IgM antibodies, and  after washing to remove the unbound HRP-conjugate, TMB solutions are added to the wells. In presence of the anti-μ chain)-(anti-HBc IgM)-(HBcAg-Ab(HRP) immunocomplex, the colorless TMB are hydrolyzed by the bound HRP-conjugate to a blue-colored product. The blue color turns yellow after stopping the reaction with sulfuric acid. The amount of color intensity can be measured and is proportional to the amount of antibody captured in the wells, and to the sample respectively. Wells containing samples negative for anti-HBc IgM remain colorless.
Reagents And Materials Provided Microplate: 96 well polystyrene microplate (12 strips of 8 wells) coated with anti-IgM antibodies (anti-μ chain).
Negative Control: 0.5ml, 1 vial;
Positive Control: 0.5ml, 1 vial;                                                         
HRP-Conjugate: 12ml, 1 vial;                                                         
TMB Solution A: 7ml, 1 vial;                                                       
TMB Solution B: 7ml, 1 vial;                                                       
TMB Stop Solution: 7ml, 1 vial;                                                       
Wash Buffer (20×): 30ml, 1 vial;
Microtiter plate sealers:  2 sheets;
 Plastic Sealable Bag: 1 unit.
Materials Required But Not Supplied
1. Validated microplate reader.
2. Eppendorf Tubes for dilution for samples and standards.
3. Deionized or distilled water.
4. Validated adjustable micropipettes, single and multi-channel.
5. Automatic microtiter plate washer or manual vacuum aspiration equipment.
6. 37°C incubator.
Storage Unopened Kit: Store at 2 - 8°C. Do not use past kit expiration date.
Opened/Reconstituted Reagents: TMB Solution A; TMB Solution B; TMB Stop Solution; Wash Buffer; HRP-conjugate antibody
The above mentioned reagents should be stored for up to 1 month at 2 - 8°C.
Microplate Wells: Return unused wells to the foil pouch containing the desiccant pack, reseal along entire edge of zip-seal. May be stored for up to 1 month at 2 - 8°C.
Precautions 1. The kit should be equilibrated to room temperature (20-23) before opening any vials and starting the assay. It is highly recommended that the solutions be used as soon as possible after rehydration.
2. When mixing or reconstituting protein solutions, always avoid foaming.
3. Do not mix or substitute reagents with those from other lots or sources.
4. To avoid cross-contamination, change pipette tips between additions of each standard level, between sample additions, and between reagent additions. Also, use separate reservoirs for each reagent.
5. Crystals could appear in the 20X wash solution due to high salt concentration in the stock solutions. Crystals are readily dissolved at room temperature or at 37°C before dilution of the buffer solutions.
6. Keep TMB Substrate protected from light.
7. The Stop Solution provided with this kit is an acid solution. Wear eye, hand, face, and clothing protection when using this material.
Specimen Treatment Centrifuge the serum, plasma or cell culture supernatant samples for 10 minutes at 1,000×g. Remove particulates and assay immediately or aliquot and store samples at -20°C or -80°C. Avoid repeated freeze-thaw cycles.
ELISA Procedure 1. Allow the reagents and samples to reach room temperature for at least 15-30 minutes. Check the Wash buffer concentrate for the presence of salt crystals. If crystals have formed in the solution, resolubilize by warming at 37 until crystals dissolve. Dilute the stock Wash Buffer with 570 ml distilled or deionized water. Use only clean vessels to dilute the buffer. Mark three wells as Negative control (e.g. B1, C1, D1), two wells as Positive control (e.g. E1, F1) and one Blank. (e.g. A1, neither samples or HRP-Conjugate should be added into the Blank well). If the results will be determined by using dual wavelength plate reader, the requirement for use of Blank well could be omitted.  Use only number of strips required for the test.
2. Dilute each sample 1:1000 with normal saline (Do not dilute the controls, they are ready to use as supplied). 
3. Add  100μl of samples and  100 μl Positive and Negative controls and into their respective wells, Cover the plate with the plate cover and incubate for  30 minutes at 37.
4. At the end of the incubation, remove and discard the plate cover. Wash each well 5 times with diluted Wash buffer. Each time, allow the microwells to soak for 30-60 seconds. After the final washing cycle, turn the plate down onto blotting paper or clean towel, and tap it to remove any remainders.
5. Add 100 μl of HRP-Conjugate antibody into each well except for the Blank. Cover the plate with the plate cover and incubate for  30 minutes at 37.
6. Dispense 50 µl of TMB Solution A and 50 µl TMB Solution B into each well including the Blank, and mix by tapping the plate gently. Incubate the plate at 37 for 10 minutes avoiding light. The enzymatic reaction between the TMB solutions and the HRP-Conjugate produces blue color in Positive control and HBeAg positive sample wells.
7. Remove and discard the plate cover. Aspirate the liquid and rinse each well  5 times with Wash buffer (as step 4). After the final washing cycle, turn the strip plate and tap out any remainders.
8. Dispense 50 µl of TMB Solution A and 50 µl TMB Solution B solution into each well including the Blank, and mix by tapping the plate gently. Incubate the plate at 37 for 15 minutes avoiding light.  The enzymatic reaction between the
TMB solutions and the HRP-Conjugate antibody produces blue color in Positive control and anti-HBc IgM positive sample wells.
Interpretation Of Results And Quality Control
Each microplate should be considered separately when calculating and interpreting results of the assay, regardless of the number of plates concurrently processed. The results are calculated by relating each sample’s optical density (OD) value to the Cut-off value (C.O.) of the plate. If the Cut-off reading is based on single filter plate reader, the results should be calculated by subtracting the Blank well OD value from the print report values of samples and controls. In case the reading is based on dual filter plate reader, do not subtract the Blank well OD from the print report values of samples and controls.
1. Calculation of Cut-off value:
 Cut-off value (C.O.) = *Nc × 2.1
*Nc = the mean absorbance value for three negative controls.
Important: If the mean OD value of the negative control is lower than 0.05, take it as 0.05.
If one of the Negative control values does not meet the Quality control range specifications, it should be discarded and the mean value is calculated again using the remaining two values. If more than one negative control OD value does not meet the Quality control range specifications, the test is invalid and must be repeated.
2. Quality control range:
The test results are valid if the Quality Control criteria are verified. It is recommended that each laboratory must establish appropriate quality control system with quality control material similar to or identical with the patient sample being analyzed
1) The OD value of the Blank well, which contains only Chromogens and Stop solution, is less than 0.080 at 450 nm.
2) The OD value of the Positive control must be equal to or greater than 0.500 at 450/630nm, or at 450nm after blanking.
3) The OD value of the Negative control must be less than 0.100 at 450/630nm or at 450nm after blanking.
3. Interpretations of the results:
(S = the individual optical density (OD) of each specimen)
Negative Results (S/C.O.<1): samples giving absorbance less than the Cut-off value are negative for this assay, which indicates that no IgM-class antibodies to hepatitis B core antigen have been detected with this anti-HBc IgM ELISA kit.
Positive Results (S/C.O.1): samples giving an absorbance greater than, or equal to the Cut-off value are initially reactive, which indicates that IgM-class antibodies to hepatitis B core antigen have probably been detected with this anti-HBc IgM ELISA kit. Any reactive samples should be retested in duplicates. Repeatedly reactive samples could be considered positive for anti-HBc IgM. Positive results with anti-HBc IgM detection indicate possible recent infection with HBV.
Borderline: Samples with absorbance to Cut-off ratio between 0.9 and 1.1 are considered borderline samples and retesting of these samples in duplicates is recommended. Repeatedly positive samples can be considered positive for anti-HBc IgM.
The result from this assay should not be used alone to establish the infection state.
1. Non- repeatable reactive results may be obtained with any ELISA test due to the general characteristics of this diagnostic method. A negative result with an antibody detection test does not preclude the possibility of infection. Antibodies could also be undetectable during the early stages of the disease and in some immunosuppressed individuals.
2. If, after retesting of the initially reactive samples, the assay results are negative, these samples should be considered as non-repeatable (false positive) and interpreted as negative. As with many very sensitive ELISA assays, false positive results can occur due to the several reasons, most of which are related but not limited to inadequate washing step.
3. Any positive results must be interpreted in conjunction with patient clinical information and other laboratory testing results.
4. Common sources for mistakes: kits beyond the expiry date, bad washing procedures, contaminated reagents, incorrect assay procedure steps, insufficient aspiration during washing, failure to add samples or reagents, equipment, timing, volumes, sample nature and quality.
5. The prevalence of the marker will affect the assay’s predictive values.
6. This kit is intended ONLY for testing of individual serum or plasma samples. Do not use it for testing of cadaver samples, saliva, urine or other body fluids, or pooled (mixed) blood.
7. This is a qualitative assay and the results cannot be use to measure antigens concentrations.
Indications Of Instability Or Deterioration Of The Reagents 1. Values of the Positive or Negative controls, which are out of the indicated Quality control range, are indicator of possible deterioration of the reagents and/or operator or equipment errors. In such case, the results should be considered as invalid and the samples must be retested. In case of constant erroneous results classified as due to deterioration or instability of the reagents, immediately substitute the reagents with new ones, or contact our technical support for further assistance.
2. If after mixing of the TMB Solution A and B into the wells, the color of the mixture turns blue within few minutes, do not continue carrying out the testing and replace the reagents with fresh ones.
Online Inquiry